ARCHIVES

Dendritic Cell Vaccine Increases PFS in Phase II Clinical Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Carter Wants His Own Man, So Cooper Is Out; New Preventive Oncology Society Established

January 14, 1977

Tamoxifen Offers Long-Term Benefits For Prevention

March 30, 2007

13th Congress Advance Program Announcement Now Available

May 1, 1981

FDA Advisors Okay NCI Toxicology Proposals, Write New Clinical Guidelines, Approve AIN DA

October 19, 1979

In Brief: Benjamin Neel named director of NYU Cancer Center

October 24, 2014

Cervical Cancer Screening Can Be Done Later, Less Often

December 25, 2009